Trademark Overview
On Monday, November 27, 2023, a trademark application was filed for MATRICELF with the United States Patent and Trademark Office. The USPTO has given the MATRICELF trademark a serial number of 79391456. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Saturday, June 29, 2024. This trademark is owned by Matricelf Ltd.. The MATRICELF trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Biological implants; biological tissue for implantation; biological tissue cultures for medical purposes; engineered biological tissues for medical purposes; engineered human biological tissues for use in regenerative medicine; engineered biological tissues for the treatment of spinal cord injuries; biological implants for spinal cord injuries; bio-printed personalized medical implants comprised of living tissue; a personalized bio-printed medical tissue implant adapted to fill a surgically defined cavity; transplants [living tissues]; surgical implants comprising engineered living tissue; surgical implants grown from stem cells; engineered human hydrogel and differentiated stem cells in the nature of biological tissues for medical purposes; engineered human hydrogel for medical purposes; stem cells for medical purposes; biomaterials in the nature of biological tissue cells for printing engineered tissues for medical purposes
Regenerative medicine services; medical services, namely tissue regeneration services; medical services, namely tissue regeneration services using tissue engineering technology; medical services, namely, cellular therapy services; medical services, namely regenerating or restoration of spinal cord tissue by means of implanting engineered tissues in the spinal cord; treating human tissues for medical purposes [biomedical services]; medical services relating to the removal, treatment and processing of human tissues; medical services relating to the removal, treatment and processing of human tissues for implantation
Scientific services relating to processing human tissues and cells; medical and scientific research and development of human tissues and stem cells; medical and scientific research and development in the field of personalized medicine 3D bioprinting; stem cell research services; scientific and technological services in the field of regenerative medicine; medical and scientific research and development in the field of regenerative medicine; medical and scientific research and development in the field of spinal cord injuries; pharmaceutical and biological research and development services in the field of tissue regeneration and engineering
